Public Markets 3 Hours

Last updated: March 31, 2026, 8:30 PM ET

Geopolitical Shift Sparks Market Reassessment

Hopes for a swift diplomatic resolution in the Middle East are driving a marked risk-on sentiment across Asian markets, with stocks poised to track a euphoric Wall Street rally following President Trump’s declaration that the US aims to end the war in Iran within two to three weeks. This optimism is directly impacting commodities, causing gold to edge higher as de-escalation fears alleviate concerns regarding oil price spikes and aggressive central bank tightening; specifically, gold maintained three days of gains after the President’s remarks signaled a conclusion to the conflict. However, the recent instability is leaving scars on regional trade, as evidenced by Australia’s manufacturing sector slipping into contraction in March—its first such decline in five months—due to weakened demand and surging costs stemming from the war disruptions.

Aviation & Logistics Navigate Supply Chain Stress

While broader economic indicators reflect recent conflict disruption, select logistics firms are demonstrating surprising resilience. MTT Shipping and Logistics Bhd. is forging ahead with its April initial public offering and expansion plans, successfully shrugging off Middle Eastern disruptions because current cargo volumes remain steady. In contrast, the broader energy supply chain is facing immediate rerouting challenges, forcing New York to send jet fuel to England as the conflict throws global aviation fuel distribution into disarray. Meanwhile, condemnation continues over localized violence, with the U.N. Security Council denouncing deadly roadside bomb attacks against peacekeepers in south Lebanon, urging de-escalation between Israel and Hezbollah.

Private Credit and Regulatory Hurdles

In financial structuring, the private credit market continues to draw substantial capital, as Blue Owl Capital successfully closed its Asset Special Opportunities Fund IX, raising $2.9 billion in total commitments, surpassing its initial $2.5 billion target and confirming investor appetite for niche credit offerings. This activity contrasts sharply with ongoing regulatory disputes, where the Justice Department is struggling to formulate a response to President Trump’s lawsuit demanding $10 billion from the I.R.S., fueling complicated internal debates within the administration. Separately, the pharmaceutical sector is seeing deal sizing narrow, with approximately three-quarters of M&A transactions this year occurring in the $1 billion to $10 billion bracket, suggesting large-scale transformational mergers are becoming less common.